Biomapas is established and conducts its first BE studies
Phase I-IV Clinical Trials are initiated
First studies performed in the CIS region.
First PK/PD Studies with Biologicals/Biosimilars.
The Pharmacovigilance department is established.
The Regulatory Affairs department is established.
Biomapas adds Medical Devices services to its portfolio and completes first projects.
Biomapas completes the ISO 9001:2008 to ensure high-quality services for its clients.
The launch of Clinical Safety and Medical Monitoring services
New offices open up in Russia and Georgia.
New office opens up in Switzerland.
New office opens up in Ukraine.
Integrated ISO 9001:2015 and ISO 13485:2016
New office opens up in Sweden.
New office opens up in Poland.
New office opens up in Kazakhstan.
Biomapas adds Medical Information to its portfolio and consolidates its position as a partner from Early development to Post-Marketing.
World Drugs Safety Congress Europe
Meet us at the international partnering event to discuss the key challenges in drug safety on October 6-7th in Amsterdam.
World Drug Safety Congress Americas
Our team is looking forward to meeting you and see how we can support your development at the World Drug Safety Congress Americas in Boston, USA, October 20-21st, 2021.
Meet up with us at BIO-Europe on October 25-28th to build partnerships that facilitate innovation together.
Join us at the leading pharma event CPhI this November, from 9th to the 11th, 2021. Our team is looking forward to meeting you there.